For citations:
Alexandrovich Yu.S., Alekseeva E.I., Bakradze M.D., Baranov A.A., Batysheva T.T., Vashakmadze N.D., Vershinina M.G., Vishneva E.A., Glazyrina A.A., Gordeeva O.B., Dyakonova E.Yu., Zholobova Е.S., Zabolotsky D.V., Zvereva N.N., Zelenkova I.V., Ivanov D.O., Kaytukova E.V., Karkashadze G.A., Konovalov I.V., Kruchko D.S., Kulichenko T.V., Kurbanova S.Kh., Levina Y.G., Lobzin Yu.V., Mazankova L.N., Margieva T.V., Namazova-Baranova L.S., Novikova Yu.Yu., Ovsyannikov D.Yu., Petryaykina E.E., Petrenko Yu.V., Petrova N.V., Prometnoy D.V., Pshenisov K.V., Revunenkov G.V., Rtishchev A.Yu., Rusinova D.S., Sayfullin M.A., Sayfullin R.F., Selimzyanova L.R., Tatochenko V.K., Tepaev R.F., Uskov A.N., Fedoseenko M.V., Fisenko A.P., Khar’kin A.V., Efendieva K.E., Yakovlev A.V. Clinical Features and Management of the Disease Caused by New Coronaviral Infection (COVID-19) in Children. Version 2. Pediatric pharmacology. 2020;17(3):187-212. (In Russ.) https://doi.org/10.15690/pf.v17i3.2123
Email this article 